Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: Case report

Pathology International

Volumn 61, Issue 6, 2011, Pages 363-368

  Niino, Daisuke ^a   Ohsaki, Koichi ^a   Arakawa, Fumiko ^a   Watanabe, Jiro ^b   Kimura, Yoshizo ^a   Kiyasu, Junichi ^a   Takeuchi, Masanori ^a   Miyoshi, Hiroaki ^a   Yoshida, Maki ^a   Sugita, Yasuo ^a   Ohshima, Koichi ^a   Okamura, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yame General Hospital   (Japan)

Author keywords

Composite lymphoma; Diffuse large B cell lymphoma; Lymphoblastic leukemia lymphoma

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON REGULATORY FACTOR 4; LACTATE DEHYDROGENASE; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; SOLUBLE INTERLEUKIN 2 RECEPTOR; T6 ANTIGEN; VINCRISTINE;

AGED; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; COMPOSITE LYMPHOMA; COMPOSITE T LYMPHOBLASTIC LEUKEMIA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LEUKEMIA REMISSION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHATIC LEUKEMIA; LYMPHOCYTIC INFILTRATION; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLENOMEGALY; TREATMENT RESPONSE;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMPOSITE LYMPHOMA; CYCLOPHOSPHAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; DNA, NEOPLASM; DOXORUBICIN; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; L-LACTATE DEHYDROGENASE; LYMPHOMA, LARGE B-CELL, DIFFUSE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; RECEPTORS, INTERLEUKIN-2; TREATMENT OUTCOME; VINCRISTINE;

EID: 79957539173     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02662.x     Document Type: Article

References (30)

1. Custer R. Pitfalls in the diagnosis of lymphoma and leukemia from the pathologist's point of view. Proceedings from the 2nd National Cancer Conference, vol 1, American Cancer Society, New York; 1954: 554-7.
2. Gonzalez CL, Medeiros LJ, Jaffe ES. Composite lymphoma: A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Am J Clin Pathol 1991; 96: 81-9.
3. Paulli M, Rosso R, Kindl S etal. Nodular sclerosing Hodgkin's disease and large cell lymphoma: Immunophenotypic characterization of a composite case. Virchows Arch A Pathol Anat Histopathol 1992; 421: 271-5.
4. Steinhoff M, Hummel M, Assaf C etal. Cutaneous T cell lymphoma and classic Hodgkin lymphoma of the B cell type within a single lymph node: Composite lymphoma. J Clin Pathol 2004; 57: 329-31.
5. Mittal BB, Nalesnik M. Composite lymphoma (Hodgkin's and non-Hodgkin's) of the spleen in a previously untreated patient. Acta Haematol 1986; 76: 29-32.
6. Hull PR, Saxena A. Mycosis fungoides and chronic lymphocytic leukemia: Composite T-cell and B-cell lymphomas presenting in the skin. Br J Dermatol 2000; 143: 439-44.
7. Liu YC, Tomashefski JF Jr, Cleveland RP, Nassar SJ, Trey JE. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: Morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement. Mod Pathol 1994; 7: 641-6.
8. Volk AL, Vannucci SA, Cook W, Thompson KA, Listinsky CM. Composite mycosis fungoides and B-cell chronic lymphocytic leukemia. Ann Diagn Pathol 2002; 6: 172-82.
9. Zettl A, Lee SS, Rudiger T etal. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002; 117: 368-79.
10. Xu Y, McKenna RW, Hoang MP, Collins RH, Kroft SH. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: A case report and review of the literature. Am J Clin Pathol 2002; 118: 848-54.
11. Chen YK, Huang E, Lin CC etal. Composite lymphoma: Angiocentric T-cell lymphoma (CD8+ cytotoxic/suppressor T-cell) and diffuse large B-cell lymphoma associated with EBV, and presenting clinically as a midfacial necrotizing lesion. Oral Oncol 2004; 40: 353-59.
12. Swerdlow SH, Campo E, Harris NL etal. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 2008.
13. Ohshima K, Haraoka S, Suzumiya J, Kawasaki C, Kanda M, Kikuchi M. Cytoplasmic cytokines in lymphoproliferative disorders: Multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 2000; 38: 541-5.
14. Rappaport H, Winter WJ, Hicks EB. Follicular lymphoma: A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 1956; 9: 792-821.
15. Kim H, Hendrickson R, Dorfman RF. Composite lymphoma. Cancer 1977; 40: 959-76.
16. Brauninger A, Hansmann ML, Strickler JG etal. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 1999; 340: 1239-47.
17. Jaffe ES, Zarate-Osorno A, Kingma DW, Raffeld M, Medeiros LJ. The interrelationship between Hodgkin's disease and nonHodgkin's lymphomas. Ann Oncol 1994; 5: 7-11.
18. Tsang P, Pan L, Cesarman E, Tepler J, Knowles DM. A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. Hum Pathol 1999; 30: 988-92.
19. Hancock JC, Wells A, Halling KC etal. Composite B-cell and T-cell lymphoma arising 24 years after nodular lymphocyte predominant Hodgkin's disease. Ann Diagn Pathol 1999; 3: 23-34.
20. Tobinai K, Ohtsu T, Hayashi M etal. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. Leuk Res 1991; 15: 837-46.
21. York JC, Cousar JB, Glick AD, Flexner JM, Stein R, Collins RD. Morphologic and immunologic evidence of composite B- and T-cell lymphomas. A report of three cases developing in follicular center cell lymphomas. Am J Clin Pathol 1985; 84: 35-43.
22. Tokunaga M, Tokudome T, Shimizu S etal. Biclonality of composite B- and T-cell lymphomas. A case report. Acta Pathol Jpn 1990; 40: 522-30.
23. Hirose Y, Fukushima T, Masaki Y etal. Epstein-Barr virus-associated composite lymphoma composed of peripheral T-cell lymphoma and an anaplastic variant of a diffuse large B-cell type of non-Hodgkin's lymphoma and strongly expressing p53 protein. Int J Hematol 2004; 79: 260-65.
24. Kaleem Z, McGuire MH, Caracioni AC etal. Composite B-cell and T-cell non-hodgkin lymphoma of the tibia. Am J Clin Pathol 2005; 123: 215-21.
25. Xie H, Orkin SH. Immunology: Change destiny. Nature 2007; 449: 410-11.
26. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-4.
27. Ho JW, Ho FC, Chan AC, Liang RH, Srivastava G. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 1998; 185: 79-85.
28. Medeiros L, Stetler-Stevenson M. Composite B-cell and T-cell lymphoma: Coincidental occurence or related neoplasm. Am J Clin Pathol 1992; 98: 387-9.
29. Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med 1979; 300: 452-8.
30. Toner GC, Sinclair A, Sutherland RC, Schwartz MA. Composite lymphoma. Am J Clin Pathol 1986; 86: 375-8.